GlassScriptPhysician profile
John M Baldauf
NPI 1891773479
$116,977.41
in general payments reported to CMS, 2019-2025
21 companies · $10K in 2025
The $10K reported for 2025 was more than what 87% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $55K · 2020: $37K · 2021: $2,012 · 2022: $1,031 · 2023: $6,093 · 2024: $5,930 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Consulting Fee: $7,000 · Travel and Lodging: $5,095.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,374.54 |
| Consulting Fee | $7,000.00 |
| Travel and Lodging | $5,094.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, LP | $89,014.83 | 2019-2020 | |
| Medacta USA, INC. | $19,605.74 | 2022-2025 | Primary Shoulder, Gmk Sphere, Amistem |
| Stryker Corporation | $3,806.85 | 2019-2025 | Mako, Triathlon, Aequalis Perform Reversed |
| Pacira Therapeutics, INC. | $1,766.70 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $1,428.49 | 2019-2025 | Euflexxa |
| Sanara Medtech INC. | $376.03 | 2021-2025 | Celleraterx, Biasurge, Celleraterx |
| Pacira Pharmaceuticals Incorporated | $174.49 | 2021-2025 | Zilretta, Iovera, Exparel |
| Vertex Pharmaceuticals Incorporated | $172.13 | 2025 | |
| Ethicon US, LLC | $115.12 | 2019-2024 | Ethicon, Evarrest, Surgiflo Hemostatic Matrix |
| Skeletal Dynamics INC | $114.50 | 2023 | Geminus, Implate, Align |
| Boston Scientific Corporation | $70.35 | 2021-2024 | |
| Acera Surgical, INC. | $62.69 | 2022-2024 | Restrata Wound Matrix |
| Depuy Synthes Sales INC. | $56.35 | 2019-2022 | |
| Heron Therapeutics, INC. | $51.82 | 2021-2025 | Zynrelef |
| Smith+Nephew, INC. | $37.74 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xtant Medical INC | $34.34 | 2023 | |
| Anika Therapeutics, INC. | $33.30 | 2024 | Ovo Motion, Revomotion, X-Twist |
| Avanos Medical | $16.65 | 2022 | |
| Si-Bone, INC. | $13.94 | 2020 | |
| Intuitive Surgical, INC. | $13.53 | 2023 | Da Vinci Surgical System |
| Johnson & Johnson Health Care Systems INC. | $11.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Baldauf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.